Markers of coagulation and fibrinolysis do not detect or predict the presence of left atrial appendage thrombus in patients with atrial fibrillation

Autor: Ersin Doğanözü, Orçun Çiftci, Senem Hasırcı, Kerem Can Yilmaz, Emir Karacaglar, Leyla Elif Sade, Ibrahim Haldun Muderrisoglu, Mehmet Bülent Özin
Jazyk: English<br />Turkish
Rok vydání: 2020
Předmět:
Zdroj: Türk Kardiyoloji Derneği Arşivi, Vol 48, Iss 2, Pp 109-115 (2020)
Druh dokumentu: article
ISSN: 1016-5169
DOI: 10.5543/tkda.2019.38585
Popis: Objective: This study was designed to evaluate the role of hemostatic variables in arterial blood serum in left atrial thrombosis and to define any hemostatic variables, such as serum biomarkers, that could potentially reduce the need for transesophageal echocardiography. Methods: This study included patients with non-valvular asymptomatic atrial fibrillation (AF), either paroxysmal, persistent, or chronic. The presence of an left atrial appendix (LAA) thrombus was used to form 2 groups: thrombus (+) and thrombus (-). The serum levels of the thrombotic/fibrinolytic markers including beta-thromboglobulin, prothrombin fragment 1+2, thrombin/antithrombin complex, human plasminogen activator inhibitor-1/tissue plasminogen activator complex, and D-dimer were compared between 2 groups. Results: The mean age of the study population was 65.6+-12.2 years (range: 30–96 years), and 33 (61.1%) patients were male. Fourteen (25.9%) patients had an LAA thrombus and 40 patients did not. Two groups did not differ significantly with regard to any of the coagulation/fibrinolysis markers. The LAA thrombus (+) group had significantly higher rates of heart failure, peripheral artery disease, coronary artery disease, and chronic obstructive pulmonary disease (p
Databáze: Directory of Open Access Journals